Produkty 13007-32-4

CAS 13007-32-4 występuje w naszej ofercie pod nazwami: Lacto-N-neotetraose, >95% (HPLC), Lacto–N–neotetraose, Lacto-N-neotetraose, Lacto-N-neotetraose 98%, Lacto-N-neotetraose, 98%, 98%. Oferty producentów: TRC, GLPBio, TargetMol, Biosynth, Ambeed. Dostępne opakowania: 10mg, 1mg, 5mg, 25mg, 50mg, 100mg, 250mg, 5 mg.

Lacto-N-neotetraose, >95% (HPLC)
TRC
  • opakowanie: 10mg, 1mg, 5mg
  • Warianty: 3
Zobacz produkt
Lacto–N–neotetraose
GLPBio
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 1341,24
Zobacz produkt
Lacto-N-neotetraose
TargetMol, Biosynth
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 8
od 1329,18
Zobacz produkt
Lacto-N-neotetraose 98%
Ambeed
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 7
od 298,06
Zobacz produkt
Lacto-N-neotetraose, 98%, 98%
Chemat
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
od 515,60
Zobacz produkt
Lacto-N-neotetraose, 99.64%
MedChemExpress
  • opakowanie: 5 mg, 10 mg, 25 mg, 1 mg
  • Warianty: 4
od 407,93
Zobacz produkt
Lacto-N-neotetraose, min. 95 %, 5 mg
Roth
  • opakowanie: 5mg
  • Warianty: 1
od 2902,56
Zobacz produkt
Lacto-N-neotetraose, min. 95 %, 50 mg
Roth
  • opakowanie: 50mg
  • Warianty: 1
od 19440,04
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide (CAS 13007-32-4) to związek chemiczny o wzorze sumarycznym C26H45NO21 i masie molowej 707.6 g/mol. Nazwa systematyczna IUPAC: N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide. InChIKey: RBMYDHMFFAVMMM-PLQWBNBWSA-N.

Dane identyfikacyjne
Wzór sumarycznyC26H45NO21
Masa molowa707.6 g/mol
Nazwa IUPACN-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
InChIKeyRBMYDHMFFAVMMM-PLQWBNBWSA-N
SMILESCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)CO)O)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: lacto-N-neotetraose, N-NEOTETRAOSE, LNnT, Neolactotetraose, NLCOSE, Lactulose Impurity 26, Gal-b-1,4-GlcNAc-b-1,3-Gal-b-1,4-Glc, Lacto-N-neotetraose ,>=95%, orb1981755, lacto-N-neo-tetraose from human milk
Izomery (ten sam wzór sumaryczny)
N-[(2S,3R,4R,5R,6R)-2-[(2R,3R,4S,5R)-1,2-dihydroxy-6-oxo-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide C26H45NO21
N-[(2S,3R,4R,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide C26H45NO21
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide C26H45NO21